SleepCogni raises £1.4m to enter US sleep market

SleepTech start-up SleepCogni has raised £1.4m ($2m) to scale the business to commercialise into the US market, with the potential to help over 70m insomnia sufferers. SleepCogni has developed a ground-breaking treatment for insomnia that allows users to control their wind down process using a unique handheld medical device and platform. In their recent clinical […]

x

Enter your email to get your report and free sleep guide

See our Privacy Policy to learn how we protect your data under strict European privacy laws.

Thank you, you'll receive your report soon

Join the exclusive early access list

Get early access when SleepCogni launches later in 2026 — first release limited to 100 devices.

By submitting your email, you agree to our Privacy Policy and how we process your personal data.